Confidentiality Contracts Designs Settlement 
Intepat
JUNE 19, 2023
The various forms of intellectual property are already well known- trademarks, patents, copyrights, industrial designs, trade secrets, domain names and geographical indications. Things to Keep in Mind Maintaining Secrecy – Only inventions and designs which are not previously disclosed can be registered for patents and industrial designs.
LexBlog IP
DECEMBER 20, 2023
. “Customers” here includes both individual consumers and corporate entities who have entered into a contract for data processing services.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Technology & Marketing Law Blog
DECEMBER 15, 2021
The Lenz case got a lot of press, but it ended with a confidential settlement. The precedent work is “a set of replacement stickers for the dashboard climate controls for certain GM vehicles”: The Copyright Office registered this design. Defendant had not obtained the Deposit Design from the Copyright Office.
Biswajit Sarkar Copyright Blog
MAY 7, 2021
In the case of Alice Corp v CLS Bank International, the US Supreme Court in 2014 held that claims to a computer-associated technique of mitigating “settlement risk” in various financial transactions were barred from patenting. An opt-in scheme could address the confidentiality concerns of IP owners.
Biswajit Sarkar Copyright Blog
MAY 7, 2021
In the case of Alice Corp v CLS Bank International, the US Supreme Court in 2014 held that claims to a computer-associated technique of mitigating “settlement risk” in various financial transactions were barred from patenting. An opt-in scheme could address the confidentiality concerns of IP owners.
Biswajit Sarkar Copyright Blog
MAY 7, 2021
In the case of Alice Corp v CLS Bank International, the US Supreme Court in 2014 held that claims to a computer-associated technique of mitigating “settlement risk” in various financial transactions were barred from patenting. An opt-in scheme could address the confidentiality concerns of IP owners.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. Note that FDA still has not designated any biosimilar as interchangeable to its reference product. No earlier than July 31, 2023 per settlement. No earlier than November 20, 2023 per settlement. . Introduction.
Expert insights. Personalized for you.
52 
Let's personalize your content